Human Metabolome Technologies Inc. (6090) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Human Metabolome Technologies Inc. (6090:JPX), powered by AI.

Current Price
¥706
Sector
Healthcare
What is the Human Metabolome Technologies Inc. stock price forecast?

Human Metabolome Technologies Inc. is currently trading at ¥706. View real-time AI analysis on Alpha Lenz.

What is Human Metabolome Technologies Inc. insider trading activity?

View the latest insider trading data for Human Metabolome Technologies Inc. on Alpha Lenz.

What is Human Metabolome Technologies Inc.'s P/E ratio?

View Human Metabolome Technologies Inc.'s valuation metrics on Alpha Lenz.

Human Metabolome Technologies Inc.

JPX · 6090
¥706
Ask about Human Metabolome Technologies Inc.'s future dividend policy...
Alpha Chat Insight

Human Metabolome Technologies Inc.'s ROE is 13.3%. Explore profitability and growth together.

Ask for details

Company Overview

Human Metabolome Technologies Inc. is an innovative entity within the biotechnology sector, focused on providing comprehensive metabolomics services and products. The company's primary function is to analyze and quantify small molecules known as metabolites within biological samples. Their cutting-edge technology plays a crucial role in supporting drug discovery, diagnostics development, and therapeutic research. Human Metabolome Technologies Inc. addresses various industries, including pharmaceuticals, healthcare, and academic research. By leveraging advanced analytical methods, the company enables clients to gain insights into metabolic functions and pathways, ultimately enhancing understanding of diseases and biological processes. Established with a vision to pioneer metabolic profiling, Human Metabolome Technologies Inc. continues to be a significant contributor to advancements in life sciences and personalized medicine.

CEOMr. Katsuhito Hashizume
SectorHealthcare
IndustryDiagnostics & Research
Employees62

Company Statistics

FY 2025

Profile

N/AMarket Cap
¥1,455,004,000Revenue
0.00Shares Out
62Employees

Margins

63.35%Gross
23.87%EBITDA
17.15%Operating
18.54%Pre-Tax
17.62%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

5.95%Rev 3Yr
5.40%Rev 5Yr
9.29%Op Inc 3Yr
N/AOp Inc 5Yr
-1.44%Net Inc 3Yr
N/ANet Inc 5Yr

Returns

10.30%ROA
13.30%ROE
10.94%ROIC

Financial Health

¥1,562,417,000Cash & Cash Equivalents
¥-1,096,406,000Net Debt
24.42%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Human Metabolome Technologies Inc. (ticker: 6090) is a company listed on JPX in the Healthcare sector (Diagnostics & Research). It has approximately 62 employees.

The current price is 706 with a P/E ratio of -x and P/B of -x.

ROE is 13.30% and operating margin is 17.15%. Annual revenue is $1.5B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Human Metabolome Technologies Inc. (Healthcare) Stock Forecast & Analysis ¥706 | Alpha Lenz